lysyl-ketoprofen
Small moleculeexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 23, 2018 (NCT04678076)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Cyclooxygenase-2INHIBITOR
PTGS2 inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1.NCCCC[C@H](N)C(=O)O- Mol. weight
- 400.48 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Racemic Mixture
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4650345 ↗
Also known as
- lysyl-ketoprofen
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04802967 | Phase 1 | Feb 8, 2021 | Dompe Pharmaceuticals, MAC Clinical Research |
| NCT04678076 | Phase 1 | Jul 23, 2018 | Angelini, Cross Research S.A. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Angelini | For profit | 1 | 1 | 1 | 2018 |
| Cross Research S.A. | For profit | 1 | 0 | 1 | 2018 |
| Dompe Pharmaceuticals | For profit | 1 | 1 | 1 | 2021 |
| MAC Clinical Research | For profit | 1 | 0 | 1 | 2021 |
4 organizations
Page 1 / 1